Trial Details
ACTIVE_NOT_RECRUITINGBasic Information
| Clinical ID | c420 |
|---|---|
| Identifier | NCT06636656 |
| Trial Title | A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: BI 3032950 intravenous (Part A)|DRUG: BI 3032950 subcutaneous (Part B) |
Participant Information
| Sponsor | Boehringer Ingelheim |
|---|---|
| City | Scottsdale |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2024-12-11 |
|---|---|
| Primary Completion Date | 2026-01-14 |
| Completion Date | 2028-02-29 |